Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1999
11/11/1999DE19819829A1 New nucleic acid encoding a nicotinic acetylcholine receptor from insects, used to identify potential insecticides
11/11/1999DE19805815C1 Diagnostikum zum Erkennen der autoimmunen Hepatitis Diagnostic tool for the detection of autoimmune hepatitis
11/11/1999CA2650642A1 Neisseria meningitidis antigens and compositions
11/11/1999CA2331844A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999CA2331139A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein
11/11/1999CA2330944A1 Pathogeniv tau mutations
11/11/1999CA2330838A1 Neisseria meningitidis antigens and compositions
11/11/1999CA2330765A1 Nucleic acids that control seed and fruit development in plants
11/11/1999CA2330699A1 Multifunctional adhesin proteins and their display in microbial cells
11/11/1999CA2330665A1 Protein mixtures to induce therapeutic angiogenesis
11/11/1999CA2328506A1 Modifying the expression of the fsh beta gene by homologous recombination
11/11/1999CA2328505A1 Chimeric receptors
11/11/1999CA2328495A1 Vaccine for pseudomonas aeruginosa
11/11/1999CA2328483A1 Inhibitors of nf-kb activation
11/11/1999CA2328476A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
11/11/1999CA2328459A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
11/11/1999CA2328132A1 Growth-associated protease inhibitor heavy chain precursor
11/11/1999CA2328112A1 Methods for diagnosing and evaluating cancer
11/11/1999CA2328108A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999CA2328059A1 Use of interleukin-18 as vaccine adjuvant
11/11/1999CA2327584A1 Attenuated influenza viruses
11/11/1999CA2327550A1 Melanocortin 1 receptor selective compounds
11/11/1999CA2327543A1 Method of treating bladder and lower urinary tract syndromes
11/11/1999CA2327539A1 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999CA2327526A1 Thrombolytic agents derived from streptokinase
11/11/1999CA2327509A1 Pth2 receptor selective compounds
11/11/1999CA2327457A1 Secreted proteins and polynucleotides encoding them
11/11/1999CA2327355A1 Human receptor molecules
11/11/1999CA2327316A1 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
11/11/1999CA2327263A1 Human protease associated proteins
11/11/1999CA2327259A1 Human transcriptional regulator molecules
11/11/1999CA2326957A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same
11/11/1999CA2326956A1 Human bmp-4 promoter and method for exploring bone-related substance by using the same
11/11/1999CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999CA2326402A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/11/1999CA2326065A1 Method for treating cytokine mediated hepatic injury
11/11/1999CA2325567A1 Optimization of pest resistance genes using dna shuffling
11/11/1999CA2295510A1 Use of a nuclease inhibitor or interleukin-10 (il-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy
11/11/1999CA2271326A1 Dtf-a gene, diagnostic and therapeutic uses thereof
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955382A2 Polymorphisms associated with hypertension
11/10/1999EP0955373A2 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/10/1999EP0955370A2 DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs
11/10/1999EP0955367A2 Recombinant nucleoprotein of toscana virus
11/10/1999EP0955366A1 Antigenic protein originating in malassezia
11/10/1999EP0955365A2 Crystallization of M-CSF
11/10/1999EP0955364A2 Eukaryotic transposable element
11/10/1999EP0955361A1 Monoclonal antibodies to tumor-associated antigens, methods for their production, and their use
11/10/1999EP0955314A2 Peptide analogues of glucagon-like-peptide-1 (7-37), their preparation and pharmaceutical compositions
11/10/1999EP0955313A1 Novel protein and process for producing the same
11/10/1999EP0955312A2 Antimicrobial peptide
11/10/1999EP0954605A1 Method and probes for the identification of microbial genes specifically induced during host infection
11/10/1999EP0954602A1 Hereditary hemochromatosis gene
11/10/1999EP0954599A1 Reagents and methods useful for detecting diseases of the prostate
11/10/1999EP0954594A2 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages
11/10/1999EP0954593A1 Recombinant pox virus for immunization against tumor-associated antigens
11/10/1999EP0954592A1 System for the production of aav vectors
11/10/1999EP0954591A2 Mini-adenoviral vector
11/10/1999EP0954589A1 Synthetic leader peptide sequences
11/10/1999EP0954588A1 Ob fusion protein compositions and methods
11/10/1999EP0954586A1 Methods of reducing the levels of protoporphyrin ix in recombinant hemoglobin preparations
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954582A1 Polynucleotide vaccine against canine distemper
11/10/1999EP0954581A2 Gene expression regulatory dna, expression cassette, expression vector and transgenic plant
11/10/1999EP0954580A1 Human sdf-5 protein and compositions
11/10/1999EP0954579A1 Gene therapy for obesity
11/10/1999EP0954578A1 Glycoprotein hormone superagonists
11/10/1999EP0954577A2 Secreted proteins and polynucleotides encoding them
11/10/1999EP0954576A2 Cd16-ii variants
11/10/1999EP0954575A2 Cerebellum and embryo specific protein
11/10/1999EP0954533A1 Von willebrand factor derivative and method for isolating proteins
11/10/1999EP0954532A1 Novel human apoptosis regulator
11/10/1999EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999EP0954530A1 Immunomodulatory peptides of vespid antigen 5
11/10/1999EP0954529A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
11/10/1999EP0954528A1 A method for chromatographic removal of prions
11/10/1999EP0954527A1 Glycine transporter-transfected cells and uses thereof
11/10/1999EP0954525A1 Novel compounds
11/10/1999EP0954524A1 A process for purifying apolipoproteins and a composition for use in the process
11/10/1999EP0954523A1 Improved method for the production of soluble collagen
11/10/1999EP0954334A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
11/10/1999EP0954333A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/10/1999EP0954332A1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
11/10/1999EP0954331A1 Novel compounds
11/10/1999EP0954330A1 Intestinal trefoil proteins
11/10/1999EP0954326A1 A process for viral inactivation of lyophilized blood proteins
11/10/1999EP0954324A1 Cyclic peptide vaccines for treatment and prevention of diabetes
11/10/1999EP0724588B1 Drug binding protein
11/10/1999EP0715721B1 Phosphate assay
11/10/1999EP0708841B1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation
11/10/1999EP0600993B1 Proteins with insecticidal properties against homopteran insects and their use in plant protection
11/10/1999EP0584256B1 Compounds and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
11/10/1999EP0575319B1 Cloning and expression of renilla luciferase
11/10/1999EP0479834B1 Competitive enzyme assay for determination of phosphothioate insecticides
11/10/1999CN1234834A Methods for preventing graft rejection in transplantation and for producing universal gene therapy host cell
11/10/1999CN1234833A Nuetrokine 'alpha'
11/10/1999CN1234806A G protein-coupled receptor antagonists
11/10/1999CN1234805A ICE inhibiting peptides
11/10/1999CN1046292C Method of chemical dressing hemoglobins used as oxygen carrier in blood substitution material